Skin Infection News and Research

RSS

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.

23 Jun 2007

Congress urged to cover home infusion therapy for Medicare beneficiaries

The Infectious Diseases Society of America (IDSA) is urging Congress to support the Medicare Home Infusion Therapy Coverage Act of 2007 (H.R. 2567), bipartisan legislation introduced yesterday by Reps.

8 Jun 2007

Superbugs out and about in the community

Researchers in the U.S. say that it is not just in hospitals that the so-called "superbugs" present a problem.

29 May 2007

Researchers discover how antibiotic linezolid inhibits bacterial growth

Researchers at the University of Illinois at Chicago, in collaboration with research teams from Pharmacia & Upjohn and Pfizer, have discovered precisely how the antibiotic linezolid inhibits bacterial growth.

11 May 2007

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

Probiotics, the "good" bacteria in many dietary supplements, might counteract an unpleasant side effect for children on antibiotics, according to a new systematic review.

20 Apr 2007

Staph infections among hospitalized patients are on the rise

The study, conducted by Gary Noskin, MD, infectious disease specialist and associate chief medical officer at Northwestern Memorial Hospital, also revealed that the increase in staph infections is resulting in millions of dollars of excess healthcare costs due to longer hospitalizations.

17 Apr 2007

FDA approves Altabax ointment for impetigo

The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.

14 Apr 2007

Vaccines for measles-mumps-rubella and varicella are effective in extremely preterm infants

The study, which included 16 term and 16 extremely preterm (born before about 6 months of pregnancy) infants born between May 2002 and May 2005, is the first of its kind to examine the antibody levels of measles, mumps, rubella and varicella in this population before and after vaccination. It was published in this month's Pediatrics.

5 Mar 2007

WHO publishes new guidelines for safe use of wastewater, excreta and greywater

In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.

11 Sep 2006

Antibiotic-resistant MRSA all too common

Researchers in the U.S. say that methicillin-resistant Staphylococcus aureus or MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.

20 Aug 2006

Research offers new hope in helping elderly fight infections

Thousands of infections could be prevented each year in older people and hospital stays reduced following findings from two studies which show that imbalances in the immune systems of people aged over 65 make them more prone to illnesses like flu or bacterial infections as a result of cuts and falls.

21 Jul 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

New therapy proven to be effective in the treatment of MRS

Cosmetic considerations and a perceived lack of patent opportunities could be stopping the pharmaceutical and healthcare industries from investing in the development of a new therapy proven to be effective in the treatment of MRSA.

6 Apr 2006

Dramatic increase in antibiotic-resistant staph infections

Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.

9 Mar 2006

Why more women die than men after heart bypass surgery

According to researchers, infections - including those acquired in hospitals, could explain why women die more frequently than men after heart bypass surgery and the explanations for this sex difference are controversial.

28 Feb 2006

Research points to a novel approach to treating serious Strep infections

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that so-called flesh-eating "Strep" bacteria use a specific enzyme to break free of the body's immune system, a finding which could potentially lead to new treatments for serious infections in human patients.

24 Feb 2006

X-linked agammaglobulinemia

Individuals who have a rare genetic immune system disorder that prevents them from making antibodies nevertheless appear to be moderately healthy and lead productive lives, according to results of a study by investigators at St. Jude Children's Research Hospital.

18 Jan 2006